Medical - Diagnostics & Research
Compare Stocks
5 / 10Stock Comparison
STRR vs ADUS vs HCSG vs CODI vs ENSG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Conglomerates
Medical - Care Facilities
STRR vs ADUS vs HCSG vs CODI vs ENSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Diagnostics & Research | Medical - Care Facilities | Medical - Care Facilities | Conglomerates | Medical - Care Facilities |
| Market Cap | $29M | $1.81B | $1.60B | $905M | $10.18B |
| Revenue (TTM) | $114M | $1.45B | $1.84B | $1.85B | $5.27B |
| Net Income (TTM) | $-6M | $100M | $59M | $-227M | $363M |
| Gross Margin | 40.9% | 32.5% | 13.3% | 38.7% | 15.2% |
| Operating Margin | -1.0% | 9.8% | 3.0% | 0.3% | 8.5% |
| Forward P/E | — | 14.3x | 21.3x | 150.4x | 23.2x |
| Total Debt | $1M | $209M | $25M | $1.88B | $4.15B |
| Cash & Equiv. | $17M | $82M | $161M | $68M | $504M |
STRR vs ADUS vs HCSG vs CODI vs ENSG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Star Equity Holding… (STRR) | 100 | 109.2 | +9.2% |
| Addus HomeCare Corp… (ADUS) | 100 | 100.6 | +0.6% |
| Healthcare Services… (HCSG) | 100 | 96.4 | -3.6% |
| Compass Diversified (CODI) | 100 | 73.5 | -26.5% |
| The Ensign Group, I… (ENSG) | 100 | 392.2 | +292.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: STRR vs ADUS vs HCSG vs CODI vs ENSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
STRR has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.19, yield 7.0%
- Lower volatility, beta 0.19, Low D/E 2.6%, current ratio 3.58x
- Beta 0.19, yield 7.0%, current ratio 3.58x
- Beta 0.19 vs HCSG's 1.12, lower leverage
ADUS is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 23.2%, EPS growth 23.2%, 3Y rev CAGR 14.4%
- PEG 0.71 vs ENSG's 1.68
- 23.2% revenue growth vs STRR's -66.9%
- Lower P/E (14.3x vs 23.2x), PEG 0.71 vs 1.68
HCSG ranks third and is worth considering specifically for momentum and efficiency.
- +55.8% vs CODI's -30.3%
- 7.3% ROA vs STRR's -8.7%, ROIC 9.0% vs -24.3%
Among these 5 stocks, CODI doesn't own a clear edge in any measured category.
ENSG is the clearest fit if your priority is long-term compounding.
- 7.5% 10Y total return vs ADUS's 399.9%
- 6.9% margin vs CODI's -12.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.2% revenue growth vs STRR's -66.9% | |
| Value | Lower P/E (14.3x vs 23.2x), PEG 0.71 vs 1.68 | |
| Quality / Margins | 6.9% margin vs CODI's -12.3% | |
| Stability / Safety | Beta 0.19 vs HCSG's 1.12, lower leverage | |
| Dividends | 7.0% yield, 1-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +55.8% vs CODI's -30.3% | |
| Efficiency (ROA) | 7.3% ROA vs STRR's -8.7%, ROIC 9.0% vs -24.3% |
STRR vs ADUS vs HCSG vs CODI vs ENSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
STRR vs ADUS vs HCSG vs CODI vs ENSG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ADUS leads in 1 of 6 categories
HCSG leads 1 • ENSG leads 1 • STRR leads 0 • CODI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — STRR and ADUS each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 46.5x STRR's $114M. ENSG is the more profitable business, keeping 6.9% of every revenue dollar as net income compared to CODI's -12.3%. On growth, STRR holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $114M | $1.4B | $1.8B | $1.8B | $5.3B |
| EBITDAEarnings before interest/tax | $2M | $159M | $72M | $109M | $558M |
| Net IncomeAfter-tax profit | -$6M | $100M | $59M | -$227M | $363M |
| Free Cash FlowCash after capex | -$10M | $137M | $139M | $10M | $406M |
| Gross MarginGross profit ÷ Revenue | +40.9% | +32.5% | +13.3% | +38.7% | +15.2% |
| Operating MarginEBIT ÷ Revenue | -1.0% | +9.8% | +3.0% | +0.3% | +8.5% |
| Net MarginNet income ÷ Revenue | -5.4% | +6.9% | +3.2% | -12.3% | +6.9% |
| FCF MarginFCF ÷ Revenue | -8.4% | +9.5% | +7.6% | +0.5% | +7.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | +7.7% | +6.6% | -5.9% | +18.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +28.2% | +17.2% | +175.0% | -5.1% | +21.9% |
Valuation Metrics
ADUS leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 18.7x trailing earnings, ADUS trades at a 37% valuation discount to ENSG's 29.8x P/E. Adjusting for growth (PEG ratio), ADUS offers better value at 0.93x vs ENSG's 2.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $29M | $1.8B | $1.6B | $905M | $10.2B |
| Enterprise ValueMkt cap + debt − cash | $13M | $1.9B | $1.5B | $2.7B | $13.8B |
| Trailing P/EPrice ÷ TTM EPS | -2.33x | 18.67x | 27.54x | -3.94x | 29.85x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.28x | 21.30x | 150.38x | 23.19x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.93x | — | — | 2.16x |
| EV / EBITDAEnterprise value multiple | — | 12.52x | 22.38x | 14.99x | 25.71x |
| Price / SalesMarket cap ÷ Revenue | 0.55x | 1.28x | 0.87x | 0.48x | 2.01x |
| Price / BookPrice ÷ Book value/share | 0.72x | 1.65x | 3.19x | 1.58x | 4.59x |
| Price / FCFMarket cap ÷ FCF | — | 17.48x | 11.49x | — | 27.46x |
Profitability & Efficiency
HCSG leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ENSG delivers a 16.6% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-50 for CODI. STRR carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to CODI's 3.27x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs STRR's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -13.0% | +9.3% | +11.8% | -49.6% | +16.6% |
| ROA (TTM)Return on assets | -8.7% | +7.0% | +7.3% | -7.3% | +6.8% |
| ROICReturn on invested capital | -24.3% | +8.8% | +9.0% | +1.0% | +7.0% |
| ROCEReturn on capital employed | -18.5% | +10.9% | +7.7% | +2.4% | +10.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 7 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.03x | 0.19x | 0.05x | 3.27x | 1.86x |
| Net DebtTotal debt minus cash | -$16M | $127M | -$136M | $1.8B | $3.7B |
| Cash & Equiv.Liquid assets | $17M | $82M | $161M | $68M | $504M |
| Total DebtShort + long-term debt | $1M | $209M | $25M | $1.9B | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | -47.19x | 14.45x | 33.02x | -0.97x | 88.33x |
Total Returns (Dividends Reinvested)
ENSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $4,995 for STRR. Over the past 12 months, HCSG leads with a +55.8% total return vs CODI's -30.3%. The 3-year compound annual growth rate (CAGR) favors ENSG at 23.6% vs STRR's -25.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -13.3% | -8.7% | +28.6% | +158.7% | +0.3% |
| 1-Year ReturnPast 12 months | -7.0% | -13.4% | +55.8% | -30.3% | +27.5% |
| 3-Year ReturnCumulative with dividends | -58.8% | +16.3% | +48.6% | -25.6% | +88.9% |
| 5-Year ReturnCumulative with dividends | -50.1% | +0.0% | -21.1% | -35.5% | +103.2% |
| 10-Year ReturnCumulative with dividends | +50.6% | +399.9% | -26.8% | +53.7% | +752.0% |
| CAGR (3Y)Annualised 3-year return | -25.6% | +5.2% | +14.1% | -9.4% | +23.6% |
Risk & Volatility
Evenly matched — STRR and HCSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
STRR is the less volatile stock with a 0.19 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 91.5% from its 52-week high vs CODI's 68.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.19x | 0.57x | 1.14x | 1.28x | 0.38x |
| 52-Week HighHighest price in past year | $11.99 | $124.44 | $24.39 | $17.46 | $218.00 |
| 52-Week LowLowest price in past year | $1.99 | $90.89 | $12.66 | $4.58 | $133.81 |
| % of 52W HighCurrent price vs 52-week peak | +77.1% | +78.2% | +91.5% | +68.9% | +80.0% |
| RSI (14)Momentum oscillator 0–100 | 44.6 | 49.3 | 61.8 | 70.0 | 23.3 |
| Avg Volume (50D)Average daily shares traded | 7K | 236K | 676K | 1.2M | 358K |
Analyst Outlook
Evenly matched — STRR and HCSG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ADUS as "Buy", HCSG as "Hold", CODI as "Hold", ENSG as "Buy". Consensus price targets imply 32.3% upside for ADUS (target: $129) vs 9.8% for HCSG (target: $25). For income investors, STRR offers the higher dividend yield at 7.01% vs ENSG's 0.14%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $128.67 | $24.50 | $15.00 | $222.33 |
| # AnalystsCovering analysts | — | 16 | 15 | 14 | 13 |
| Dividend YieldAnnual dividend ÷ price | +7.0% | — | — | +4.2% | +0.1% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 20 | 0 | 12 |
| Dividend / ShareAnnual DPS | $0.65 | — | — | $0.50 | $0.24 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | 0.0% | +3.9% | +0.0% | +0.2% |
ADUS leads in 1 of 6 categories (Valuation Metrics). HCSG leads in 1 (Profitability & Efficiency). 3 tied.
STRR vs ADUS vs HCSG vs CODI vs ENSG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is STRR or ADUS or HCSG or CODI or ENSG a better buy right now?
For growth investors, Addus HomeCare Corporation (ADUS) is the stronger pick with 23.
2% revenue growth year-over-year, versus -66. 9% for Star Equity Holdings, Inc. (STRR). Addus HomeCare Corporation (ADUS) offers the better valuation at 18. 7x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate Addus HomeCare Corporation (ADUS) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — STRR or ADUS or HCSG or CODI or ENSG?
On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 18.
7x versus The Ensign Group, Inc. at 29. 8x. On forward P/E, Addus HomeCare Corporation is actually cheaper at 14. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 71x versus The Ensign Group, Inc. 's 1. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — STRR or ADUS or HCSG or CODI or ENSG?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +103. 2%, compared to -50. 1% for Star Equity Holdings, Inc. (STRR). Over 10 years, the gap is even starker: ENSG returned +738. 2% versus HCSG's -24. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — STRR or ADUS or HCSG or CODI or ENSG?
By beta (market sensitivity over 5 years), Star Equity Holdings, Inc.
(STRR) is the lower-risk stock at 0. 19β versus Compass Diversified's 1. 28β — meaning CODI is approximately 569% more volatile than STRR relative to the S&P 500. On balance sheet safety, Star Equity Holdings, Inc. (STRR) carries a lower debt/equity ratio of 3% versus 3% for Compass Diversified — giving it more financial flexibility in a downturn.
05Which is growing faster — STRR or ADUS or HCSG or CODI or ENSG?
By revenue growth (latest reported year), Addus HomeCare Corporation (ADUS) is pulling ahead at 23.
2% versus -66. 9% for Star Equity Holdings, Inc. (STRR). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -1426. 1% for Compass Diversified. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — STRR or ADUS or HCSG or CODI or ENSG?
The Ensign Group, Inc.
(ENSG) is the more profitable company, earning 6. 8% net margin versus -19. 6% for Star Equity Holdings, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9. 7% versus -15. 8% for STRR. At the gross margin level — before operating expenses — CODI leads at 38. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is STRR or ADUS or HCSG or CODI or ENSG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 71x versus The Ensign Group, Inc. 's 1. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 14. 3x forward P/E versus 150. 4x for Compass Diversified — 136. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ADUS: 32. 3% to $128. 67.
08Which pays a better dividend — STRR or ADUS or HCSG or CODI or ENSG?
In this comparison, STRR (7.
0% yield), CODI (4. 2% yield), ENSG (0. 1% yield) pay a dividend. ADUS, HCSG do not pay a meaningful dividend and should not be held primarily for income.
09Is STRR or ADUS or HCSG or CODI or ENSG better for a retirement portfolio?
For long-horizon retirement investors, Star Equity Holdings, Inc.
(STRR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 19), 7. 0% yield). Both have compounded well over 10 years (STRR: +50. 6%, HCSG: -24. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between STRR and ADUS and HCSG and CODI and ENSG?
These companies operate in different sectors (STRR (Healthcare) and ADUS (Healthcare) and HCSG (Healthcare) and CODI (Industrials) and ENSG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: STRR is a small-cap income-oriented stock; ADUS is a small-cap high-growth stock; HCSG is a small-cap quality compounder stock; CODI is a small-cap income-oriented stock; ENSG is a mid-cap high-growth stock. STRR, CODI pay a dividend while ADUS, HCSG, ENSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.